Foresite Capital Fund V L.P. 13D/13G Filings for Compass Therapeutics, Inc. (CMPX)

Foresite Capital Fund V L.P. 13D and 13G filings for Compass Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
5:20 pm
Purchase		 2022-12-31 13G Compass Therapeutics, Inc.
CMPX		 Foresite Capital Fund V L.P. 5,954,250
4.700%		 454,250increase
(+8.26%)		 Filing
2021-11-12
06:10 am
Purchase		 2021-11-02 13G Compass Therapeutics, Inc.
CMPX		 Foresite Capital Fund V L.P. 5,500,000
5.600%		 5,500,000increase
(New Position)		 Filing